Effect of Pomalidomide-based regimen on the treatment of patients with first-relapsed multiple myeloma and analysis of prognostic factors
POM-based regimen can significantly improve the PFS and overall response rate in patients with first-relapsed MM. The use of POM is a protective factor, extramedullary plasmacytoma, risk stratification, and LDH>240 U/L are independent risk factors for PFS.
Authors
- Qihang Man
- Qing Fan (ORCID: https://orcid.org/0000-0003-3395-8971)
- Yu Wang (ORCID: https://orcid.org/0000-0002-6008-810X)
Institutions
- Shunyi Hospital of Beijing Traditional Chinese Medicine Hospital (CN)
Publication Details
- Journal
- Pakistan Journal of Medical Sciences
- Published
- 2025-06-03
- DOI
- https://doi.org/10.12669/pjms.41.6.10472
- Primary Topic
- Multiple Myeloma Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00